1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders-Revised 3rd ed. Washington, D. C: American Psychiatric Association.
2. Bowen DM, Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Palmer AM, Sins NR, Smith CC, Spillane JA, Esiri MM, Neary D, Snowdon JS, Wilcock GK, Davison AN (1983) Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer’s disease. J Neurochem 41:266–272
3. Burns A, Jacoby R, Levy R (1990a) Psychiatric phenomena in Alzheimer’s disease. I: disorders of thought content. Brit J Psychiat 157:72–76
4. Burns A, Jacoby R, Levy (1990b) Psychiatric phenomena in Alzheimer’s disease. II. Disorders of perception. Brit J Psychiat 157:76–81
5. Carlsson A, Adofsson R, Aquilonius S-M, Goffries CG, Oreland L, Svennerholm L, Win-blad B (1980) Biogenic amines in human brain in normal aging, senile dementia and chronic alcoholism. In: Goldstein M et al. (eds) Ergot compounds and brain function: neuroendocrine and neuropsychiatric aspects. New York, Raven Press, pp 295–304